<div id="readability-page-1"><p>Amdocs (NASDAQ:DOX - Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 7.340-7.480 for the period, compared to the consensus earnings per share estimate of 7.310. The company issued revenue guidance of $4.6 billion-$4.7 billion, compared to the consensus revenue estimate of $4.7 billion. Amdocs also updated its Q3 2026 guidance to 1.810-1.870 EPS.</p><h2>Amdocs Stock Performance</h2><p>Amdocs stock traded down $2.41 during trading hours on Wednesday, hitting $59.93. 1,810,046 shares of the stock traded hands, compared to its average volume of 1,226,916. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. Amdocs has a 1 year low of $59.40 and a 1 year high of $95.41. The stock has a market capitalization of $6.47 billion, a price-to-earnings ratio of 11.59, a P/E/G ratio of 1.11 and a beta of 0.40. The firm's 50 day moving average price is $65.71 and its 200-day moving average price is $73.96. </p><h2>Analyst Ratings Changes</h2><p>A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Amdocs from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, April 18th. Weiss Ratings  reiterated a &#34;hold (c-)&#34; rating on shares of Amdocs in a research report on Friday. Barclays lowered their price objective on Amdocs from $111.00 to $92.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, February 4th. Finally, Stifel Nicolaus dropped their target price on shares of Amdocs from $97.00 to $88.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have assigned  a Hold rating to the company. According to data from MarketBeat.com, the company  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $92.33.</p><p><b>Get Our Latest Analysis on Amdocs</b></p><h2>Key Stories Impacting Amdocs</h2><p>Here are the key news stories impacting Amdocs this week:</p><ul>   <li><span>Positive Sentiment: </span>Amdocs posted fiscal second-quarter revenue of $1.17 billion and non-GAAP EPS of $1.78, both at or above guidance expectations, while also reaffirming its full-year revenue and free cash flow outlook. <i></i><span>Amdocs Limited Reports Second Quarter Fiscal 2026 Results</span></li>   <li><span>Positive Sentiment: </span>The company announced several new and expanded customer wins, including a multi-year agreement with Telefónica Móviles Argentina and continued cloud migration work with Lumen Technologies, supporting the backlog and long-term revenue visibility. <i></i><span>Telefónica Móviles Argentina Signs Strategic Multi-Year Agreement with Amdocs to Advance its Operational Excellence</span> <i></i><span>Lumen Technologies Accelerates Cloud-First Strategy with Amdocs, Expands Migration of Enterprise Billing Platform to Microsoft Azure</span></li>   <li><span>Positive Sentiment: </span>Amdocs also highlighted product momentum in AI and cloud, including Telco Agents in Google’s Gemini Enterprise Agent Marketplace and a benchmark-setting entitlement server on Microsoft Azure, which may support its longer-term growth narrative. <i></i><span>Amdocs Announces Availability of Telco Agents for Customer Experience in Google's Gemini Enterprise Agent Marketplace</span> <i></i><span>Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure</span></li>   <li><span>Neutral Sentiment: </span>Management also announced that long-time CFO Tamar Rapaport-Dagim will retire, with internal successor Tal Rozenfeld taking over June 1. The planned transition is orderly, but leadership changes can still create some investor caution. <i></i><span>Amdocs Limited Reports Second Quarter Fiscal 2026 Results</span></li>   <li><span>Negative Sentiment: </span>Despite the earnings beat, operating margin came in lower on a GAAP basis due to transition-related costs, and a market article noted Amdocs was among several shares under pressure, suggesting investors may be taking profits or rotating out of the name after recent gains. <i></i><span>Everforth, Amdocs, Booz Allen Hamilton, Broadridge, and CBIZ shares plummet, what you need to know</span></li> </ul><h2>Institutional Trading of Amdocs</h2><p>Large investors have recently modified their holdings of the stock. EP Wealth Advisors LLC acquired a new stake in  Amdocs in the fourth quarter valued at approximately $631,000.  Mackenzie Financial Corp boosted its position in shares of  Amdocs by 218.0% in the 4th quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company's stock valued at $9,644,000 after purchasing an additional 81,504 shares during the period.  NewEdge Advisors LLC grew its position in shares of  Amdocs by 8.6% during the fourth quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company's stock worth $908,000 after acquiring an additional 897 shares during the last quarter.  Empowered Funds LLC grew its position in  Amdocs by 97.4% during the 4th quarter. Empowered Funds LLC now owns 41,466 shares of the technology company's stock worth $3,338,000 after purchasing an additional 20,460 shares during the last quarter.  Finally, XTX Topco Ltd grew its position in  Amdocs by 41.2% during the 4th quarter. XTX Topco Ltd now owns 14,183 shares of the technology company's stock worth $1,142,000 after purchasing an additional 4,139 shares during the last quarter. Hedge funds and other institutional investors own  92.02% of the company's stock. </p><h2>About Amdocs</h2> (Get Free Report)<p>Amdocs <span>NASDAQ: DOX<span></span></span> is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.  </p><p>Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Amdocs</li><li>D-Wave Earnings Looked Weak, But Investors May Be Missing This</li><li>Nebius Upside Expands as AI Feedback Loop Intensifies</li><li>Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell</li><li>Plug Power Flips The Switch On Profitability</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9Y?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9Y"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Amdocs Right Now?</h2><p>Before you consider Amdocs, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.</p><p>While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Amdocs (NASDAQ:DOX) has updated its FY 2026 earnings guidance, projecting EPS between 7.340-7.480, surpassing the consensus estimate of 7.310. Revenue guidance is set at $4.6 billion-$4.7 billion, slightly below the consensus of $4.7 billion. The company also revised its Q3 2026 EPS guidance to 1.810-1.870. Despite a recent stock decline, analysts maintain a consensus rating of "Moderate Buy" with a target price of $92.33. Amdocs continues to show positive momentum with new customer agreements and advancements in AI and cloud services, although leadership changes may cause investor caution.</p>

Market Beat

Amdocs

Telefonica

Telefonica Deutschland Holding AG

TECHNOLOGY & TELECOMMUNICA ACQ CORP

Lumen Tech

Alphabet

Alphabet - C

Microsoft

Everforth

Booz Allen Hamilton

Broadridge Financial Solution

CBIZ

Empire Petroleum

Wealth Management Inc

Brown Advisory US Smaller Companies PLC GBP

Nano Labs

IGM Biosciences

IGC Pharma

Change, Inc. (Japan)

ISHRS S&P Gsti Tech

Mackenzie Realty Capital

McKay Securities PLC

Daishinku Corp.,

3EDGE Dynamic US Equity ETF

MRBL Enhanced Equity ETF

Impact Shares YWCA Women Empowerment

First Trust Morningstar Div Leaders Index Fd

LG QRAFT AI-Powered US Large Cap Core ETF

TELEFONICA SA SPON ADR EACH REP 1 ORD SHS

Tech & Telecommunication Acquisition - UNIT

Tech & Telecommunication Acquisition

TECHNOLOGY & TELECOMMUNICA ACQ CORP C/WTS 15/04/2027 (TO PUR COM)

Amdocs (NASDAQ:DOX) Releases FY 2026 Earnings Guidance